Radar · Industry landscape · France
Life Sciences Landscape of France
1,597 Life Sciences companies in France, in one picture: who is hiring, who is raising money, who founded them, where they are based, what the news is about, which skills employers want and where the research is going. Updated August 2026.
1,597companies tracked
$15Bdisclosed funding
140hiring right now
841events · 24 months
≥429,562news articles · 12 months
Who leads Life Sciences in France
Shows the top Life Sciences firms in France by size, funding, hiring activity and media coverage, highlighting companies such as Guerbet, DBV Technologies and the 140 firms currently recruiting.
open roles
Hiring now
ranked by live open roles
- 01
Guerbet9last posted May 2026
- 02
Septodont9last posted May 2026
- 03
EA Pharma8last posted May 2026
- 04
Nemera7last posted May 2026
- 05
Withings7last posted May 2026
- 06
TISSIUM6last posted May 2026
- 07
UroMems6last posted Jul 2026
- 08
Ethypharm6last posted Jan 2026
140 companies hiring · 2 posted in the last 30 days
disclosed funding
Most funded
disclosed totals, all rounds
- 01
DBV Technologies$681MPost IPO · Apr 2025
- 02
Valneva$441MPost IPO · Oct 2022
- 03
Inventiva Pharma$433.2MPost IPO · Oct 2024
- 04
Genfit$424.8MPost IPO · Oct 2017
- 05
Owkin$355.6MSeries B · Mar 2026
- 06
Abivax$319.6MPost IPO · Feb 2023
- 07
DNA Script$309.3MGrant (prize money) · Sep 2023
- 08
Amolyt Pharma$292.3MSeries C · Jan 2023
493 companies with disclosed rounds · $15B total
revenue
Revenue leaders
official filings first, else latest snapshot
- 01
- 02
Cegedim$732MFY2021 filing
- 03
- 04
OSE Immunotherapeutics$83MFY2021 filing
- 05
- 06
Proteor$64.2MFY2015 filing
- 07
Innate Pharma$62.3MFY2016 filing
- 08
Stephanix$60.4MFY2024 filing
42 companies with a revenue figure
headcount
Largest teams
ranked by tracked headcount
- 01
- 02
Nutrition & sante924tracked employees
- 03
- 04
- 05
- 06
Anthogyr400tracked employees
- 07
Hemodia400tracked employees
- 08
BioSerenity340tracked employees
180 companies with headcount data
share of events
Share of voice
share of all tracked sector news events, 24 months
- 01
- 02
Polaris3.6%44 tracked events
- 03
- 04
EDAP TMS3.3%41 tracked events
- 05
- 06
- 07
AFYREN2.9%36 tracked events
- 08
Fermentalg2.9%36 tracked events
1,227 tracked events across 156 companies
articles
In the news
Prism news coverage, last 12 months
- 01
Medtech≥127articles in the window
- 02
RDS≥72articles in the window
- 03
Nanobiotix≥59articles in the window
- 04
- 05
- 06
- 07
- 08
GenSight Biologics≥35articles in the window
147 of these companies drew sector coverage in the window
Radar
See all 1,597 Life Sciences companies in France
Filter by funding, headcount, hiring and location, and export the list.
How the Life Sciences ecosystem in France grew, 2016–2025
Lists the number of new Life Sciences companies founded each year from 2016 to 2025, with the highest count of 79 in 2016 and only 2 in 2025.
Companies founded / year
new Life Sciences companies in France
20162025
peak 79 in 2016
Companies raising / year
with a disclosed round that year
20162025
peak 109 in 2019
Disclosed funding / year
sum of disclosed rounds (USD)
20162025
peak $1.7B in 2021
Where Life Sciences companies in France are based
Ranks French cities by the count of Life Sciences companies, with Paris leading at 333 firms followed by Lyon, Montpellier, Toulouse and Marseille.
Hub 01
Paris
333 Life Sciences companies
57% of the Life Sciences companies across these hubs
333companies
$6.1Bdisclosed funding
38hiring now
Hub 02
Lyon
73 Life Sciences companies
13% of the Life Sciences companies across these hubs
73companies
$1.2Bdisclosed funding
7hiring now
Hub 03
Montpellier
36 Life Sciences companies
6% of the Life Sciences companies across these hubs
36companies
$463.7Mdisclosed funding
2hiring now
Hub 04
Toulouse
34 Life Sciences companies
6% of the Life Sciences companies across these hubs
34companies
$77.5Mdisclosed funding
6hiring now
Hub 05
Marseille
31 Life Sciences companies
5% of the Life Sciences companies across these hubs
31companies
$740Mdisclosed funding
1hiring now
Hub 06
Nantes
27 Life Sciences companies
5% of the Life Sciences companies across these hubs
27companies
$99.2Mdisclosed funding
1hiring now
Hub 07
Strasbourg
26 Life Sciences companies
4% of the Life Sciences companies across these hubs
26companies
$223.4Mdisclosed funding
Hub 08
Grenoble
21 Life Sciences companies
4% of the Life Sciences companies across these hubs
21companies
$373.6Mdisclosed funding
3hiring now
The Life Sciences market map of France: what these companies actually do
Breaks down the main product categories these firms develop—enterprise tech, medical devices, biopharmaceuticals, healthtech and deep tech—and the prevalent revenue models such as physical commerce and subscriptions.
- Enterprise Tech1,023 companies · $13.8B raised · 101 hiring
- Medical Devices398 companies · $3.7B raised · 47 hiring
- Biopharmaceuticals280 companies · $8.3B raised · 19 hiring
- Healthtech224 companies · $2B raised · 17 hiring
- Deep Tech209 companies · $2.8B raised · 18 hiring
- Enterprise Software195 companies · $2.1B raised · 17 hiring
- Consumer Digital151 companies · $736.6M raised · 15 hiring
- In Vitro Diagnostics73 companies · $266.8M raised · 5 hiring
- SaaS60 companies · $1B raised · 5 hiring
- Healthtech SaaS46 companies · $512.3M raised · 3 hiring
- IoT in Healthcare43 companies · $430.7M raised · 3 hiring
- Cancer Immunotherapy40 companies · $1.6B raised · 5 hiring
Monetization
How Life Sciences companies make money
How many companies earn revenue each way. Plenty use more than one model, so the counts add up to more than the sector.
Physical Commerce843
E-Commerce - Product650
Subscription447
Fee-For-Service258
Commission on Transaction24
Advertising12
E-Commerce - Service5
Sponsorship1
Funding, M&A and the deals moving Life Sciences in France
Counts 841 corporate events over the past two years, including earnings releases, funding rounds, key‑person announcements and mergers and acquisitions.
Earnings 223Funding 208Leadership 109Announcement 70M&A 63Contracts 48Capital 36IPO 33Regulatory 14Board Updates 11
- M&ALa Caisse and health-care private equity firm Archimed Diagnostics have bought Stago, a French company specialized in the analysis of blood coagulation issues.2026-04-29
- M&AStereotaxis has acquired Robocath, a healthcare robotic assistance systems manufacturer, in a tech M&A deal valued at $20 million.2026-04-22
- FundingAdocia (Euronext Paris: FR0011184241 ADOC, the "Company"), a clinical-stage biopharmaceutical Company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity, today announced the establishment of a shareholder loan agreement with Vester Finance, repayable in new shares, with an option for the Company to repay in cash under certain conditions.2026-04-21
- M&Athe biggest acquisition in its history, taking over the entire capital of the German giant Kamax.2026-04-14
- FundingMedinCell raised another 48 million euros2026-04-08
- FundingHealthcare technology startup May Health, led by CEO and co-founder Dr. Robert Auerbach, secured $11.7 million in funding to accelerate development of its innovative treatment technology addressing infertility related to PCOS.2026-03-17
- M&ABiomemory has acquired selected assets from Catalog Technologies, a pioneer in DNA-based data storage and computing systems.2026-03-11
- M&AIn January, French news outlet La Lettre reported that Eli Lilly was pursuing a potential €15 billion ($17.4 billion) Abivax acquisition2026-03-09
- IPOListing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the capital Total number of voting rights 02/28/2026 100,590,994 105,825,5612026-03-04
- FundingBiophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund2026-02-27
Mergers and acquisitions
Deals from the last 24 months where a Life Sciences company in France was the buyer or the one bought, newest first. “Undisclosed” means the price was never published — not that the deal was worth nothing.
| Acquirer | Target | Deal value | Status | Date |
|---|---|---|---|---|
| undisclosed | Announced | 2026-04-29 | ||
| $20M | Announced | 2026-04-22 | ||
| undisclosed | Announced | 2026-04-14 | ||
| undisclosed | Announced | 2026-03-11 | ||
| $17.4B | Rumored | 2026-03-09 | ||
| undisclosed | Announced | 2026-02-23 |
Who is listing, hiring leaders, launching and winning work
Details notable corporate actions like IPO filings, leadership changes, product launches and contract wins within the sector.
IPO pipeline
16 companies listed or filing · last 24 months
CellectisIPO · Euronext Growth · CLLS · 5 reportsMar 2026
TransgeneIPO · NASDAQ, Le Nouveau Marche · TRGNY · 6 reportsFeb 2025
GenOwayIPO · Alternext · 1 reportFeb 2025
LysogeneIPO · Euronext Paris · 2 reportsFeb 2025
HybrigenicsIPO · Alternext · 1 reportFeb 2025
Leadership moves
21 tracked people moves · last 12 months
SensorionAmit Munshi · Appointment → Acting Director GeneralFeb 2026
Contract wins
17 customer wins · last 24 months
Theranexuswon biocodexFeb 2026
Safe Orthopedicswon implamedJan 2026
Mauna Kea Techwon Endotherapeutics Pty LtdSep 2025
Amoebawon metron technologyApr 2025
Regulatory & litigation
15 regulatory events · 4 tracked suits · 24 months
AdvicenneMarketing approval receivedJul 2025
- ose immunotherapeutics v group of minority shareholdersshareholder rights dispute · DismissedSep 2025
- kamax v FCA USpurchase order contract enforceability and price renegotiation dispute · VerdictMay 2025
Earnings pulse
companies reporting results · last 24 months
40 companies reporting257 company-quarters trackedbeat 11miss 6in line 3
Half of these companies grew revenue faster than +7.1%, half slower.
Who is building Life Sciences in France
Profiles 1,106 founders and CEOs across 791 companies, noting frequent alma maters like HEC Paris and prior employers such as Google and consulting firms.
Founders and chief executives12 of 1,106, from the best-funded companies on this page
Genfit, ex-Glaxosmithkline Usa, ex-Glaxosmithkline, INSEAD, 1995
Xprize, ex-Fragment, ex-Osium Ai, Weill Medical College of Cornell University, 2011
Dna Script, ex-Akuo Energy, ex-Total, MINES ParisTech
Lamed Pharma, Università degli Studi di Milano, 1977
Chairman Calyxt, ex-France Biotech. HEC School of Management 2001
Imcheck Therapeutics, ex-Theravectys, ex-Sanofi, Advancia, Paris Chamber of Commerce and Industry, 1992
Paris Saclay Cancer Cluster, ex-Marseille-Luminy Immunology Center. Paris-Saclay University 1991
Croda, ex-Arena Pharmaceuticals, Inventiva Pharma, GE. Technical University Berlin 2002, UTC MSc 2002
Hifibio Therapeutics, ex-Harbour Biomed, ex-Sanofi, Harvard Business School Executive Education, 2024
Where the founders studied
alma mater on record for 99 of 1,106 founders
HEC Paris42
INSEAD13
ESSEC Business School10
Emlyon Business School6
Massachusetts Institute of Technology6
Université Grenoble Alpes4
Imperial College London4
University of Cambridge3
Where they worked before
a previous employer on record for 6 of 1,106 founders
Google3
Boston Consulting Group2
McKinsey1
Radar
Look up the people behind Life Sciences companies in France
Search founders, executives and operators by company, role and location.
Who funds Life Sciences in France
Summarizes 1,134 funding rounds since 2016 from 719 investors, with a typical round size of about $3 million.
| Investor · most active investors since 2016 | Rounds | Led | Latest |
|---|---|---|---|
| Europa | 235 | 2 | Jan 2026 |
| Bpifrance | 163 | 49 | Apr 2026 |
| EIC Fund | 93 | 8 | Oct 2025 |
| Sofinnova Partners | 45 | 20 | Mar 2026 |
| Kurma Partners | 38 | 12 | Oct 2025 |
| Seventure Partners | 27 | 9 | Jan 2026 |
| GO CAPITAL | 22 | 10 | Feb 2026 |
| Idinvest Partners | 21 | 8 | Jul 2021 |
| Omnes Capital | 21 | 3 | May 2025 |
| UI Investissement | 18 | 2 | Oct 2025 |
Stage mix · rounds since 2016
Seed & Angel174
Series A–B294
Series C+ / PE70
Grants, debt & other596
The typical round is $3M — half were bigger, half smaller.
The biggest Life Sciences funding rounds in France
Highlights the largest disclosed funding events, including Owkin’s $180 million Series B, and lists ten other major recent rounds.
| Company | Round | Size | When | Backers |
|---|---|---|---|---|
| Series B | $180M | Nov 2021 | Sanofi | |
| Series C | $165M | Oct 2021 | Coatue, Catalio Capital Management, Columbia Threadneedle Investments +13 more | |
| Series A | $165M | Dec 2025 | Dexcel, Third Rock Ventures, Bain Capital Life Sciences +3 more | |
| Series C | $137.5M | Jan 2023 | Sofinnova Partners, ICG, Tekla Capital Management +13 more | |
| Series A | $122M | Oct 2025 | Bpifrance, Kurma Partners, Andera Partners +8 more | |
| Series C | $120M | Jan 2021 | Sigma Gestion, BNP Paribas, Caisse D Epargne +2 more | |
| Series C | $103M | Jun 2022 | Earlybird, Andera Partners, Kurma Partners +11 more | |
| Series A | $90.9M | Jun 2021 | Casdin Capital, Sofinnova Partners, Emerson Collective +2 more | |
| Series B | $80M | Jun 2022 | Bristol-Myers Squibb | |
| Series B | $80M | Sep 2021 | Sectoral, Andera Partners, ATEM Capital +10 more |
Venture round sizes · 2023–2025
<$1M5
$1–10M64
$10–50M47
$50–250M8
>$250M0
124 venture rounds with a disclosed amount in the window.
Fresh cheques · last 6 months
Post IPO$3MMay 2026
UnattributedundisclosedMay 2026
Seed$18MApr 2026
Grant (prize money)$1.5MApr 2026
Series C$33MMar 2026
What the news says about Life Sciences in France
Counts 429,562 news articles about the sector in the last year, with coverage focusing on topics such as international politics, sports events and security policies.
News volume
Life Sciences coverage across France · articles per quarter
2021Q22026Q1
peak ≥222,532 in 2025Q3 · ≥429,562 articles in the last 12 tracked months
Tone of coverage
share of articles by dominant sentiment (positive / neutral / negative)
202120232025
Positive-tone share moved 55% → 42%, negative 41% → 56% across 2021–2025.
What the coverage is about
The subjects that dominate Life Sciences news in France. The arrow shows whether each one is being written about more or less than a year ago.
- International political relations≥72,763▲+19%
- International sports competitions≥60,713▼-52%
- Security and defense policies≥42,362▲+24%
- Olympic games coverage≥32,395▼-69%
- International relations and diplomacy≥31,218▲+24%
- Nationalism and sovereignty debates≥22,274→-5%
- Professional league updates≥21,057→-5%
- Championship event highlights≥19,790▼-27%
- Government international agreements coordination≥16,931▲+15%
- Athlete transfer rumors≥15,272→+6%
Most-covered companies · last 12 months
- ≥127
- ≥72
- ≥59
- ≥51
- ≥46
- ≥46
- ≥37
- ≥35
- ≥30
- ≥28
147 Life Sciences companies here were named in the news over this period.
Prism
Watch Life Sciences coverage in France as it happens
Prism follows these subjects story by story — which companies are named, what is said about them and how the tone moves.
Momentum
The words getting louder — and quieter
Which terms are showing up in more stories than a year ago, and which are fading. The percentage is the change in how many articles mention them.
multilateral diplomacy+65%national security strategy+85%international cooperation+54%trade dispute mechanisms+55%bilateral trade+48%nuclear proliferation+92%study overseas+83%multilateralism+53%aerial bombardments+52%fire impact study+173%
olympic team selections-81%olympic trials-83%olympic venues-87%summer olympics athletics-94%olympians career highlights-92%
The pressures the press keeps returning to
Three recurring angles in France Life Sciences coverage, and whether each is getting more attention year on year (through 2025).
Regulatory Risk ▲ rising
≥380,445 articles touch this dimension · 47.8% critical tone
20212025
signals: inflation outlook, core inflation rate, inflation breakdown
Funding Momentum ▲ rising
≥71,650 articles touch this dimension · 37.5% critical tone
20212025
signals: club valuation, currency intervention policies, inflation reports fx
Growth ▲ rising
≥157,603 articles touch this dimension · 27.3% critical tone
20212025
signals: gdp growth rate, gdp acceleration, economic output growth
Life Sciences jobs in France: who is hiring and what they ask for
Reports 458 job postings from 136 employers in the past year, with a median advertised salary of $37 k per year.
458postings · last 12 months
1,153postings tracked overall
136employers advertising
$37kmedian advertised salary/yr (n=30)
What level are these roles?
Entry13
Intern33
Senior36
Lead4
Manager71
Most advertised titles
- 50
- 15
- 9
- 8
- 7
- 6
What Life Sciences research is working on
Shows 53,147 academic papers on the field, divided among identified problems, cautions and opportunities, the latter comprising the largest share.
How this field talks about itself
Life Sciences papers (gold) against all published research (grey)
Descriptive40.2% · 17.4%2.3×
Promising30.4% · 36.8%0.8×
Breakthrough14.1% · 26.1%0.5×
Problem-identifying8.3% · 10.1%0.8×
Cautionary3.5% · 4.6%0.8×
Comparative2.4% · 4.0%0.6×
Life Sciences literature runs 2.3× more “descriptive” than science at large (40.2% vs 17.4% baseline).
How the work is done
Empirical48.8%
Reviews37.2%
Methods-led11.2%
Position pieces2.2%
Theoretical0.6%
How the research reads
80% positive · 16% neutral · 4% negative, across 53,147 papers.
The institutions behind the field
- 87k
- 75k
- 61k
- 49k
- 43k
- 38k
ranked by how often their work is cited
Researchers who shaped it
Ahmad Almilaji · Reiki Nishimura · Tomofumi Osako · Yasuyuki Nishiyama · Rumiko Tashima · Masahiro Nakano · Glenn R. Gibson · Gregor Reid
The most-cited breakthroughs
- Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity · 9k cites
- In situ click chemistry generation of cyclooxygenase-2 inhibitors · 8k cites
- U1 snRNP regulates cancer cell migration and invasion in vitro · 7k cites
- Comprehensive molecular profiling of lung adenocarcinoma · 6k cites
- Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signal · 6k cites
Common problems researchers identify4,503 papers · 7 recurring themes
Problems · theme 01
Sustainable Biofuel and Biomass Production
781 papers · 17.3% of this block
▲ +11% share2022→2025 share of research on this subject
Researchers discuss challenges in using microbes and plant systems for renewable fuels and biorefinery processes.
Biofuel · Synthetic biology · Biomass · Biorefinery
“A review on the plant microbiome: Ecology, functions, and emerging trends in microbial application”
781 of these papers raise it as a problem
Problems · theme 02
Food Safety and Processing Risks
757 papers · 16.8% of this block
▲ +41% share2022→2025 share of research on this subject
Papers highlight microbial hazards and nutritional impacts linked to food manufacturing and consumer health.
Food safety · Food processing · Food products · Human health
“Microbial Risks in Food: Evaluation of Implementation of Food Safety Measures”
757 of these papers raise it as a problem
Problems · theme 03
Gene Expression and mRNA Therapeutics
711 papers · 15.8% of this block
▼ -31% share2022→2025 share of research on this subject
Studies examine cellular mechanisms, delivery methods, and regulatory concerns for RNA‑based interventions.
Messenger RNA · Gene · Cell culture · Gene expression
“Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research”
711 of these papers raise it as a problem
Problems · theme 04
Crop Nutrition and Food Security
693 papers · 15.4% of this block
▲ +23% share2022→2025 share of research on this subject
Research addresses fertilizer efficiency, nutrient uptake, and breeding strategies to sustain agricultural productivity.
Agriculture · Crop · Food security · Germplasm
“Revisiting fertilisers and fertilisation strategies for improved nutrient uptake by plants”
693 of these papers raise it as a problem
Problems · theme 05
Plant Disease Management Strategies
691 papers · 15.3% of this block
▲ +35% share2022→2025 share of research on this subject
Works explore host immunity, pathogen interactions, and integrated pest control to reduce crop losses.
Fungicide · Integrated pest management · Host · Disease management
“Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens”
691 of these papers raise it as a problem
Problems · theme 06
Antimicrobial Resistance Across Sectors
447 papers · 9.9% of this block
▲ +10% share2022→2025 share of research on this subject
Analyses focus on the spread of drug‑resistant microbes in humans, animals, and the environment.
Antibiotic resistance · Antimicrobial · Antibiotics · Drug resistance
“Antimicrobial resistance in humans, livestock and the wider environment”
447 of these papers raise it as a problem
Problems · theme 07
Miscellaneous Biological and Chemical Topics
423 papers · 9.4% of this block
▼ -32% share2022→2025 share of research on this subject
A diverse set of papers covering unrelated biochemical and sociological subjects.
Order · NAD+ kinase · Human being · Sodium
“Modalidade, polaridade e legibilidade em resumos académicos: uma análise comparativa multidisciplinar”
423 of these papers raise it as a problem
Cautions1,765 papers · 7 recurring themes
Cautions · theme 01
Cellular Toxicity and Oxidative Stress
379 papers · 21.5% of this block
▼ -20% share2022→2025 share of research on this subject
Investigations assess how experimental conditions and contaminants affect cell viability and stress responses.
In vivo · Flow cytometry · In vitro · Oxidative stress
“Effects of Microplastics on Cell Viability, Phagocytic Activity and Oxidative Stress in Human Peripheral Blood Mononuclear Cells”
379 of these papers raise it as a problem
Cautions · theme 02
Genomic Selection in Plant Breeding
257 papers · 14.6% of this block
▲ +25% share2022→2025 share of research on this subject
Authors discuss the promises and practical limits of using genomic data to improve crop traits.
Agriculture · Selection · Production · Trait
“Genomic selection in plant breeding: from theory to practice”
257 of these papers raise it as a problem
Cautions · theme 03
Feed Additives and Animal Health
245 papers · 13.9% of this block
▼ -17% share2022→2025 share of research on this subject
Research evaluates the efficacy and safety of natural compounds used to enhance livestock nutrition.
Feed additive · Animal feed · Feed conversion ratio · Health benefits
“Natural Bioactive Compounds as Feed Additives: Strategies for Sustainable and Functional Livestock Production”
245 of these papers raise it as a problem
Cautions · theme 04
Food Contaminants and Regulatory Issues
240 papers · 13.6% of this block
▲ +14% share2022→2025 share of research on this subject
Papers review safety concerns and policy considerations for emerging food additives and contaminants.
Food safety · Hygiene · Contamination · Food contaminant
“Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters”
240 of these papers raise it as a problem
Cautions · theme 05
DNA Damage and Repair Mechanisms
239 papers · 13.5% of this block
▼ -32% share2022→2025 share of research on this subject
Studies investigate how genomic instability influences disease and the challenges of accurate measurement.
Gene · DNA damage · DNA repair · Gene expression
“Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations”
239 of these papers raise it as a problem
Cautions · theme 06
Antibiotic Use and Co‑Selection Pressures
206 papers · 11.7% of this block
▲ +10% share2022→2025 share of research on this subject
Works highlight how antimicrobial practices can promote resistance alongside other environmental stressors.
Antibiotic resistance · Antibiotics · Antimicrobial · Bacteria
“Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses”
206 of these papers raise it as a problem
Cautions · theme 07
Pesticide Resistance and Management
199 papers · 11.3% of this block
▲ +16% share2022→2025 share of research on this subject
Research examines biological control options and dosing strategies to mitigate evolving pesticide tolerance.
Pesticide · Integrated pest management · PEST analysis · Biological pest control
“The use of fungal entomopathogens as endophytes in biological control: a review”
199 of these papers raise it as a problem
Opportunities22,038 papers · 7 recurring themes
Opportunities · theme 01
Advanced Antibody and Imaging Techniques
1,044 papers · 17.4% of this block
▼ -18% share2022→2025 share of research on this subject
Innovations in fluorescent labeling and flow analysis expand capabilities for in‑vivo diagnostics.
Antibody · In vivo · Fluorescence · Flow cytometry
“Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcom”
Opportunities · theme 02
Gene Regulation for Disease Therapy
1,032 papers · 17.2% of this block
▼ -26% share2022→2025 share of research on this subject
Explorations of knockdown and modulation approaches aim to control cell growth and apoptosis.
Downregulation and upregulation · Apoptosis · Gene knockdown · Cell growth
“Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing <sc”
Opportunities · theme 03
Functional Plant‑Based Foods
878 papers · 14.6% of this block
▲ +68% share2022→2025 share of research on this subject
Papers describe bioactive ingredients that support health and promote sustainable nutrition.
Health benefits · Functional food · Ingredient · Antioxidant
“Plant-based functional foods for healthy aging: current trends, bioactive compounds, and future perspectives”
Opportunities · theme 04
Epigenetic Editing and Detection
823 papers · 13.7% of this block
▼ -32% share2022→2025 share of research on this subject
Research focuses on DNA methylation tools and sensitive assays for disease‑related RNA markers.
Gene · DNA methylation · Messenger RNA · DNA damage
“Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders”
Opportunities · theme 05
Novel Antimicrobials and Biocontrol
809 papers · 13.5% of this block
▲ +25% share2022→2025 share of research on this subject
Studies identify plant‑derived compounds and postbiotic products to combat resistant microbes.
Antimicrobial · Antibiotic resistance · Biological pest control · Bacteria
“Plants as sources of new antimicrobials and resistance-modifying agents”
Opportunities · theme 06
Genetic Improvement of Crop Traits
717 papers · 11.9% of this block
▼ -22% share2022→2025 share of research on this subject
Investigations use quantitative trait loci and selection methods to boost yield and quality.
Germplasm · Trait · Quantitative trait locus · Selection
“Evaluation of Genetic Variability and Trait Interrelationships Using Advanced Wheat Lines to Increase Yield”
Opportunities · theme 07
Sustainable Biomass and Biofuel Innovations
697 papers · 11.6% of this block
▲ +29% share2022→2025 share of research on this subject
Research explores microbial fermentation and by‑product valorization for greener agriculture and energy.
Biomass · Sustainability · Agriculture · Biofuel
“Microbial Fermentation: A Sustainable Strategy for Producing High-Value Bioactive Compounds for Agriculture, Animal Feed, and Human Health”
Which of these themes are growing fastest
Problems
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Food Safety and Processing Risks▲+41%
Plant Disease Management Strategies▲+35%
Crop Nutrition and Food Security▲+23%
Sustainable Biofuel and Biomass Production▲+11%
Antimicrobial Resistance Across Sectors▲+10%
Gene Expression and mRNA Therapeutics▼-31%
Miscellaneous Biological and Chemical Topics▼-32%
Cautions
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Genomic Selection in Plant Breeding▲+25%
Pesticide Resistance and Management▲+16%
Food Contaminants and Regulatory Issues▲+14%
Antibiotic Use and Co‑Selection Pressures▲+10%
Feed Additives and Animal Health▼-17%
Cellular Toxicity and Oxidative Stress▼-20%
DNA Damage and Repair Mechanisms▼-32%
Opportunities
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Functional Plant‑Based Foods▲+68%
Sustainable Biomass and Biofuel Innovations▲+29%
Novel Antimicrobials and Biocontrol▲+25%
Advanced Antibody and Imaging Techniques▼-18%
Genetic Improvement of Crop Traits▼-22%
Gene Regulation for Disease Therapy▼-26%
Epigenetic Editing and Detection▼-32%
Prism
Go deeper on Life Sciences research and innovation
Research themes, patent activity and the companies commercialising them, in one place.
Keep going
Track Life Sciences in France beyond this page
Radar finds and filters the companies. Prism watches what is being said about them.
About this data: built from Fliar's company, founder, funding, hiring, jobs, news and research trackers, covering France. Counts are of companies we track, not of every company that exists. Updated August 2026.
Contact details
Reach this founder through Fliar Radar
Direct contact details for the people on this page are held in Fliar Radar, behind its own access controls.